Nexam Chemical appears to be one of the most promising stories on the Swedish stock market right now. Only recently, it announced its first commercial orders from no less than the world’s largest chemicals giant BASF and German Armacell. With more orders around the corner, a recent successful capital injection and an upcoming relisting from First North to Nasdaq OMX Small Cap, we believe that the newsflow in the coming months will be very positive.
In this context, we find it very interesting to note that Nexam’s Chairman of the Board, Lennart Holm, seems to have increased its already large holding in the company even further at the beginning of 2014. According to data from Swedish broker Avanza (https://www.avanza.se/aktier/om-bolaget.html/409855/nexam-chemical-holding), Lennart Holm owned 5.5% of the capital on February 17th 2014, i.e. before the directed share issue in mid-March. This compares to his holding of 5.3% on December 30th 2013, according to SIS Ägarservice. This implies that Mr Holm has bought almost 100,000 additional shares in the period December 30th until February 17th.